Radioactive dye holds promise for Alzheimer's detection

08/22/2008 | Bloomberg

U.S. scientists developed a radioactive dye called Pittsburgh Compound B that can detect Alzheimer's disease on an imaging device by binding to amyloid -- proteins linked to the condition. Backed by General Electric, the dye could help with early detection of the disease and aid drugmakers in assessing their products' efficacy in treating brain damage. Researchers are testing the dye in Alzheimer's patients with symptoms such as forgetfulness and disorientation.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ